| Product Code: ETC6745433 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
China insulin drugs and devices import shipments in 2024 continued to be dominated by top exporters such as Puerto Rico, Metropolitan France, Germany, Spain, and Italy. Despite a high concentration with a high Herfindahl-Hirschman Index (HHI) in 2024, the Compound Annual Growth Rate (CAGR) from 2020 to 2024 experienced a decline of -2.06%. Additionally, the growth rate from 2023 to 2024 saw a significant decrease of -26.63%, reflecting a challenging market environment for insulin products in China during that period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Insulin Drugs & Devices Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Insulin Drugs & Devices Market Revenues & Volume, 2022 & 2032F |
3.3 China Insulin Drugs & Devices Market - Industry Life Cycle |
3.4 China Insulin Drugs & Devices Market - Porter's Five Forces |
3.5 China Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Drugs, 2022 & 2032F |
3.6 China Insulin Drugs & Devices Market Revenues & Volume Share, By Combination drugs, 2022 & 2032F |
3.7 China Insulin Drugs & Devices Market Revenues & Volume Share, By Non-Insulin Injectable drugs, 2022 & 2032F |
3.8 China Insulin Drugs & Devices Market Revenues & Volume Share, By Insulin Device, 2022 & 2032F |
4 China Insulin Drugs & Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in China |
4.2.2 Growing awareness about diabetes management and treatment |
4.2.3 Technological advancements in insulin drugs and devices |
4.2.4 Favorable government initiatives and policies supporting diabetes care |
4.2.5 Rising disposable income leading to increased healthcare spending |
4.3 Market Restraints |
4.3.1 High cost associated with insulin drugs and devices |
4.3.2 Limited access to healthcare services in rural areas |
4.3.3 Stringent regulatory environment for new product approvals |
4.3.4 Competition from alternative therapies for diabetes management |
4.3.5 Potential side effects and safety concerns related to insulin usage |
5 China Insulin Drugs & Devices Market Trends |
6 China Insulin Drugs & Devices Market, By Types |
6.1 China Insulin Drugs & Devices Market, By Insulin Drugs |
6.1.1 Overview and Analysis |
6.1.2 China Insulin Drugs & Devices Market Revenues & Volume, By Insulin Drugs, 2022 - 2032F |
6.1.3 China Insulin Drugs & Devices Market Revenues & Volume, By Basal or Long Acting Insulins, 2022 - 2032F |
6.1.4 China Insulin Drugs & Devices Market Revenues & Volume, By Bolus or Fast Acting Insulins, 2022 - 2032F |
6.1.5 China Insulin Drugs & Devices Market Revenues & Volume, By Traditional Human Insulins, 2022 - 2032F |
6.1.6 China Insulin Drugs & Devices Market Revenues & Volume, By Biosimilar Insulins, 2022 - 2032F |
6.2 China Insulin Drugs & Devices Market, By Combination drugs |
6.2.1 Overview and Analysis |
6.2.2 China Insulin Drugs & Devices Market Revenues & Volume, By Insulin combinations, 2022 - 2032F |
6.2.3 China Insulin Drugs & Devices Market Revenues & Volume, By Oral Combinations, 2022 - 2032F |
6.3 China Insulin Drugs & Devices Market, By Non-Insulin Injectable drugs |
6.3.1 Overview and Analysis |
6.3.2 China Insulin Drugs & Devices Market Revenues & Volume, By GLP-1 receptor agonists, 2022 - 2032F |
6.3.3 China Insulin Drugs & Devices Market Revenues & Volume, By Amylin Analogue, 2022 - 2032F |
6.4 China Insulin Drugs & Devices Market, By Insulin Device |
6.4.1 Overview and Analysis |
6.4.2 China Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pumps, 2022 - 2032F |
6.4.3 China Insulin Drugs & Devices Market Revenues & Volume, By Insulin Pens, 2022 - 2032F |
6.4.4 China Insulin Drugs & Devices Market Revenues & Volume, By Insulin Syringes, 2022 - 2032F |
6.4.5 China Insulin Drugs & Devices Market Revenues & Volume, By Insulin Jet Injectors, 2022 - 2032F |
7 China Insulin Drugs & Devices Market Import-Export Trade Statistics |
7.1 China Insulin Drugs & Devices Market Export to Major Countries |
7.2 China Insulin Drugs & Devices Market Imports from Major Countries |
8 China Insulin Drugs & Devices Market Key Performance Indicators |
8.1 Percentage of population with access to diabetes screening and treatment |
8.2 Adoption rate of advanced insulin delivery devices |
8.3 Number of diabetes education programs conducted nationwide |
8.4 Average age of diabetes diagnosis in the population |
8.5 Rate of hospitalizations due to uncontrolled diabetes complications |
9 China Insulin Drugs & Devices Market - Opportunity Assessment |
9.1 China Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Drugs, 2022 & 2032F |
9.2 China Insulin Drugs & Devices Market Opportunity Assessment, By Combination drugs, 2022 & 2032F |
9.3 China Insulin Drugs & Devices Market Opportunity Assessment, By Non-Insulin Injectable drugs, 2022 & 2032F |
9.4 China Insulin Drugs & Devices Market Opportunity Assessment, By Insulin Device, 2022 & 2032F |
10 China Insulin Drugs & Devices Market - Competitive Landscape |
10.1 China Insulin Drugs & Devices Market Revenue Share, By Companies, 2025 |
10.2 China Insulin Drugs & Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here